Material
BAFF is an important prosurvival cytokine for mature B cells. However, previous studies have shown that BAFFR is already expressed at the immature B cell stage, and that the prosurvival protein Bcl-2 does not completely complement the B cell defects resulting from the absence of BAFFR or BAFF. Thus, we hypothesized that BAFF also functions to aid the differentiation of nonautoreactive immature B cells into transitional B cells and to promote their positive selection. We found that BAFFR is expressed at higher levels on nonautoreactive than on autoreactive immature B cells and that its expression correlates with that of surface IgM and with tonic BCR signaling. Our data indicate that BAFFR signaling enhances the generation of transitional CD23
2 B cells in vitro by increasing cell survival. In vivo, however, BAFFR signaling is dispensable for the generation of CD23 2 transitional B cells in the bone marrow, but it is important for the development of transitional CD23 2 T1 B cells in the spleen. Additionally, we
show that BAFF is essential for the differentiation of CD23 2 into CD23 + transitional B cells both in vitro and in vivo through a mechanism distinct from that mediating cell survival, but requiring tonic BCR signaling. In summary, our data indicate that BAFFR and tonic BCR signals cooperate to enable nonautoreactive immature B cells to differentiate into transitional B cells and to be positively selected into the naive B cell repertoire. The Journal of Immunology, 2010, 185: 000-000.
C ytokines act on cells of the immune system to regulate and coordinate their survival, differentiation, and activity. During the last decade, the cytokine BAFF (also known as BLyS) has been defined as a critically important and specific factor that promotes the survival of transitional T2, follicular, and marginal zone B cells (1) (2) (3) (4) (5) (6) . The ability of BAFF to promote B cell survival is mediated specifically through its binding to BAFFR (also known as BR3), as indicated by the similar phenotypes of mutant mice lacking BAFF or BAFFR, as well as the differences from those lacking other BAFFRs, such as transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) and B cell maturation Ag (5, (7) (8) (9) . Moreover, evidence indicates that BAFFR signaling mediates B cell survival by preventing TRAF2/TRAF3 from inhibiting the alternative NF-kB pathway (10) (11) (12) .
In recent years it has been established that the BCR generates a ligand-independent tonic signal that is also important for the survival of B cells (13) (14) (15) . This signal, moreover, synergizes with those of cytokine receptors such as IL-7R and BAFFR to promote the survival of B lymphocytes at different stages of differentiation.
Specifically, during early B cell development the pre-BCR and the IL-7R synergize to promote survival and proliferation of pre-B cells (16, 17) . In naive mature B cells both tonic BCR and BAFFR signals are necessary for B cell survival, as demonstrated by the lack of mature B cells in the absence of either signal (9, 13) . Immature B cells are the first developing B cells to express a mature BCR, in the form of IgM, on the cell surface. Whereas immature B cells still express the IL-7R, they appear to respond minimally to IL-7 (18) . In the bone marrow, immature B cells undergo a selection process that eliminates self-reactive specificities and generates the naive mature B cell repertoire in the periphery (reviewed in Refs. [19] [20] [21] . Interestingly, no cytokine so far has been found to be necessary for the survival of immature B cells during these selection events, nor for aiding their differentiation into transitional and mature B cells.
Newly developed IgM + IgD 2 CD21 2 CD23 2 bone marrow immature B cells undergo differentiation into mature peripheral B cells through an intermediate step in development called the transitional stage (22) . Transitional B cells are found in both bone marrow and spleen and retain high levels of CD24 and CD93 expression seen on immature B cells, but they also display variable expression of IgD, CD21, and CD23 (22) (23) (24) (25) . In fact, splenic transitional B cells have been further classified into three subpopulations based on differential levels of expression of these markers (26, 27) Although a similarly precise definition of transitional B cells in the bone marrow is lacking, cells resembling splenic transitional T1 and T2 B cells are present also in this tissue (22, 25, 26) . B cell dependency on BAFF is currently considered to begin at the transitional T2 B cell stage of development in the spleen (4, 5, 9) , a stage that displays a noteworthy increase in the expression of BAFFR (28) . However, development of BAFFRdeficient B cells has been only minimally assessed in competition with wild-type B cells (29) , which is a more stringent test of B cell development (30, 31) . In fact, some evidence suggests a potential role for BAFF and BAFFR at B cell stages earlier than T2. For instance, a small reduction in the number of transitional T1 B cells was observed in the spleen of BAFF and BAFFR mutant mice, although this difference was not statistically significant (5, 9, 32) . Additionally, BrdU incorporation studies have demonstrated a reduced export of bone marrow immature B cells into the spleen of BAFFR-deficient mice (7) . BAFF was also suggested to promote either the in vitro differentiation of bone marrow immature B cells or to increase the survival of newly generated transitional B cells (10) . Overall, these data suggest that BAFF may also function at the immature and transitional T1 B cell stages.
It has been shown both in mice and humans that 30-50% of the newly generated immature B cells are nonautoreactive and presumably undergo positive selection into the spleen, while as many as 50-70% are autoreactive and potentially subjected to mechanisms of negative selection (33, 34) . Interestingly, other studies have shown that only approximately half of wild-type immature bone marrow B cells express BAFFR and bind BAFF (28, 35) , suggesting that BAFF may play a role in the process of immature B cell selection. In the studies presented in this paper, we tested the hypothesis that BAFFR is expressed by nonautoreactive, but not autoreactive, immature B cells. Additionally, we evaluated whether BAFFR expression and signaling promote the differentiation of nonautoreactive immature B cells into transitional B cells, thus contributing to the positive selection process.
We found that BAFFR is indeed expressed at higher levels on nonautoreactive than on autoreactive immature B cells, and that BAFF aids the positive selection and differentiation of nonautoreactive immature B cells only when these cells also receive sufficient tonic BCR signals. Moreover, we show that BAFFR is important for the differentiation of immature B cells into CD23 2 as well as CD23 + transitional B cells, but potentially via different molecular pathways. ) mice on a C57BL/6 genetic background have been previously described (9) and were obtained from The Jackson Laboratory (Bar Harbor, ME). A/WySnJ, C57BL/6, C57BL/6.Ly5.1 (C57BL/6 mice congenic for Ly5.1, also known as B6SJL), BALB/c, and CB17 mice were purchased from The Jackson Laboratory and either used immediately or bred in our facility. All mice were bred and maintained in specific pathogen-free rooms at the Biological Resource Center at National Jewish Health (Denver, CO). All animal experiments were approved by the Institutional Animal Care and Use Committee.
Materials and Methods

Mice
Flow cytometry and Abs
Single-cell suspensions were stained with fluorescent or biotinylated mAbs against B220 (RA3-6B2), CD21 (7G6), CD23 (B3B4), CD24 (M1/69), Ly5.2 (104.2.1), CD90.1/Thy1.1 (OX-7), CD43 (S7), CD2 (RM2-5), IgM a (DS-1), IgM b (AF6-78), and IgD (11-26c-2a), which were purchased from either BD Pharmingen (San Diego, CA) or eBioscience (San Diego, CA). Biotinylated goat polyclonal anti-mouse BAFFR Abs were purchased from R&D Systems (Minneapolis, MN). Abs against IgM (R33-24.12) (40), IgD (1.3-5) (41), and CD19 (1D3) (42) , were generated in house. Biotinylated Abs were revealed with fluorochrome-conjugated streptavidin (Molecular Probes, Eugene, OR). Propidium iodide (1.25 mg/ml) was added in some experiments to exclude dead cells. Stained cells were run on a FACScan (BD Biosciences, San Jose, CA), FACSCalibur (BD Biosciences), or a CyAn analyzer (Beckman Coulter, Fullerton, CA). Flow cytometric analyses were performed on live B220
+ or CD19 + lymphocytes based on incorporation of propidium iodide and/or forward and side scatter with FlowJo software (Tree Star, Ashland, OR).
Cell sorting and microarray analysis
Bone marrow cells were isolated from femurs, tibias, and pelvises of 3-83Igi, H-2 d and 3-83Igi,Rag1 ) were analyzed for purity by comparing to unsorted samples using a FACSCalibur (BD Biosciences). The purity was .95% in all sorted cell samples. Cell pellets were flash frozen in liquid nitrogen for 15 s and stored at 280˚C until shipment to Miltenyi Biotec (Auburn, CA). RNA preparation, amplification, and hybridization to Agilent Whole Mouse Genome Oligo Microarrays 4 3 44K were performed by Miltenyi Biotec. The microarray data have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus (43) and are accessible through the series accession no. GSE22802 (http://www.ncbi. nlm.nih.gov/geo/query/acc.cgi?acc=GSE22802).
Retroviral constructs and production of retroviral particles
The murine tnfrsf13c cDNA (encoding BAFFR) was amplified with primers BAFFR-5-NotI (59-TATGCGGCCGCTGTCCCAGCTGCATGAG-39) and BAFFR-3-SalI (59-CGCGTCGACGTTCCAGCCTCCACTGC-39) and AccuTaq polymerase (Sigma-Aldrich, St. Louis, MO) from cDNA synthesized from BALB/c RNA. The PCR product was cloned between NotI and SalI in the retroviral pMSCV-IRES-GFP vector (39) to generate the pMSCV-BAFFR-IRES-GFP plasmid. The pMSCV-Flag-Bcl2-IRES-Thy1.1 (44) and pMSCV-GFP-IRES-hN-RasG12D (39) retroviral vectors were described before. All retroviral vectors encoded replication-deficient viruses. Retroviruses were produced in Phoenix cells as previously described (39) .
Generation of bone marrow chimera and retrogenic mice
Recipient mice were irradiated as described (45) . For nonretrogenic bone marrow chimeras, donor bone marrow cells depleted of RBCs were mixed at the indicated ratios and a total of 1-2 3 10 6 cells in 100 ml of PBS were injected in a tail vein of each recipient. When generating retrogenic mice, donor mice were injected i.p. with 3.75 mg of 5-fluorouracil 4 d prior to bone marrow harvest. Bone marrow cells isolated from 5-fluorouracil-treated donor mice were cultured overnight at 1 3 10 6 cells/ml in complete IMDM (Invitrogen, Carlsbad, CA) (100 U/ml penicillin, 100 mg/ml streptomycin, 0.05 mM b-mercaptoethanol, 2 mM GlutaMAX, 0.1 mM nonessential amino acids, 10% heat-inactivated FBS) supplemented with recombinant cytokines (IL-3, IL-6, and stem cell factor, a gift of Dr. Yosef Refaeli, National Jewish Health, Denver, CO). After 24 h, the cells were resuspended in 0.5 ml of complete IMDM, 1 ml of Phoenix cell supernatant containing retrovirus particles, 3.2 mg (2.1 mg/ml final) of polybrene, and recombinant cytokines and centrifuged at 1124 3 g for 1.5 h at room temperature. Cells were cultured overnight in fresh complete medium with recombinant cytokines and transduced a second time as described above. Following transduction, recipient mice received a total of 1-5 3 10 5 cells in 100 ml of PBS via tail vein injection. Mice were analyzed 5-8 wk later.
In vitro B cell differentiation and immature B cell transduction
Bone marrow cells were cultured in complete IMDM in the presence of IL-7 for 3-4 d to enrich for IgM + immature B cells. Cells were then washed twice with PBS to remove IL-7 and plated at 2-4 3 10 6 cells/ml with 10 ng/ml recombinant murine BAFF (R&D Systems) or as otherwise indicated. On subsequent days, cells were stained with Abs against B220, CD21, CD23, IgM, and IgD to determine differentiation state. For immature B cell transduction, bone marrow cells were cultured in IL-7 as above for 2-3 d and subsequently resuspended at 4-6 3 10 6 cells/ml in a mixture consisting of 0.5 ml of complete IMDM, 1 ml of retroviral supernatant, 3.2 mg of polybrene (2.1 mg/ml final), and IL-7. Cells were centrifuged at 1124 3 g for 1.5 h at room temperature and cultured overnight in fresh complete medium containing IL-7.
Statistical analysis
Statistical significance was calculated with Graphpad Prism software using a one-tailed Student's t test with equal variance (using Welch's correction when appropriate). A value of p , 0.05 was considered significant. Data are represented as means 6 SD.
Results
BAFFR is differentially expressed in autoreactive and nonautoreactive immature B cells
To test the hypothesis that BAFFR is differentially expressed by autoreactive and nonautoreactive developing B cells, we analyzed immature B cells from mouse models that generate a monoclonal population of either nonautoreactive or autoreactive immature B cells (Supplemental Table 1 preparation, their cDNAs were hybridized to Agilent whole mouse genome microarrays. Transcript levels of tnfrsf13c, the gene encoding BAFFR, were found to be ∼4-fold higher in nonautoreactive than in autoreactive immature B cells (Fig. 1B) , and in agreement with the observed differences in surface protein levels. Thus, autoreactive and nonautoreactive immature B cells differentially express BAFFR at both transcript and protein levels.
BAFFR expression correlates with IgM expression and tonic BCR signaling in immature B cells
The low expression of BAFFR observed in autoreactive immature B cells could indicate suppression by autoantigen-mediated BCR signaling, or lack of induction in the absence of tonic BCR signals.
To assess these two possibilities we analyzed BAFFR levels on immature B cells from additional mouse strains. The B1-8/3-83Igi, H-2 b mouse strain generates immature B cells, with each cell coexpressing autoreactive (3-83H/3-83k) and nonautoreactive (B1-8H/3-83k) BCRs (Supplemental Table 1 ). As a consequence, these dual BCR-expressing B cells receive both autoantigenmediated and tonic BCR signals (38 Recently, we have shown that BCR-low immature B cells display reduced levels of tonic BCR signaling and that this deficiency can be complemented by the expression of the constitutively active form of N-Ras, N-RasD12 (39) . Thus, to examine further whether tonic BCR signaling regulates BAFFR levels, we tested whether N-RasD12 expression could reestablish normal BAFFR expression on 3-83Igi-low immature B cells. BCR-low bone marrow immature B cells from 3-83Igi-low mice were enriched and transduced in cultures containing IL-7 as previously described (39) . Cells were transduced with retroviruses encoding either N-RasD12 or GFP only control and assayed for BAFFR expression by flow cytometry thereafter. We found that expression of N-RasD12 augmented BAFFR levels on the surface of BCR-low IgD 2 immature B cells, to a level similar to that of BCR-normal (3-83Igi,H-2 d ) immature B cells, whereas gfp control transduction did not (Fig. 2C, 2D) .
Overall, these data indicate that BAFFR is expressed on bone marrow IgM + IgD 2 immature B cells and its expression level correlates with that of surface IgM and tonic BCR signaling. (Fig. 3B-D) . Cultures without IL-7 (and with or without BAFF) were also characterized by significant death of CD21 2 CD23 2 immature B cells (Fig. 3D) . Importantly, although some T1-like B cells were generated even in the absence of BAFF, their frequency and numbers were significantly increased in cultures containing BAFF (Fig.  3B-D) . In contrast, generation of T2-like B cells, as measured by expression of CD23 and high levels of IgD, was strongly dependent on the presence of BAFF (Fig. 3B-D (50) . In fact, a Bcl-2 transgene appeared to genetically complement BAFFR mutant mice to restore normal frequencies of follicular mature B cells (9, 49) . In TACI-Ig transgenic mice, however, a Bcl-2 transgene only partially restored T2 and follicular B cell numbers, whereas it did not restore T3 and marginal zone B cell subsets, suggesting that BAFF does not act solely as a survival factor, but that it also participates in B cell maturation (51) . Indeed, these previous analyses did not discriminate between the survival and the accumulation of mature B cells as a result of Bcl-2 expression, and it remains possible that the absence of BAFFR signaling hinders B cell differentiation.
BAFF augments the generation of transitional B cells in vitro
To further explore whether BAFF aids the maturation of immature B cells in addition to mediating B cell survival, 3-83Igi,H-2 d nonautoreactive immature B cells generated in vitro in the presence of IL-7 were transduced with Bcl-2 or control Thy1.1 encoding vectors, and transduced B cells were assessed for dif- The Fig. 4 and data not shown) .
Overall, these data indicate that BAFF functions to promote both B cell survival and differentiation. Moreover, they indicate that differentiation of CD21 
Increased expression of BAFFR does not rescue differentiation of BCR-low immature B cells
Recently we have shown that BCR-low immature B cells are strongly impaired in their differentiation into transitional B cells both in vitro and in vivo (39). As shown above (Fig. 2B) , BCR-low immature B cells express subnormal levels of BAFFR, in addition to low levels of surface IgM. Thus, we asked whether the reduced differentiation of BCR-low immature B cells was in part due to the low expression of BAFFR and, consequently, low response to BAFF.
To test this hypothesis, we generated a retroviral construct that encodes mouse BAFFR. The functionality of the BAFFR retroviral construct was confirmed by its ability to partially restore mature B cell generation in A/WySnJ mice, which express a codominant natural mutant form of BAFFR (8, 49) (Supplemental Fig. 2) . We next transduced BCR-low immature B cells from 3-83Igi-low mice with retroviruses encoding either BAFFR or GFP only and tested the ability of transduced immature B cells to differentiate in vitro in the presence of BAFF. Importantly, transduction with the BAFFR-encoding retrovirus significantly increased levels of BAFFR on BCR-low IgD 2 immature B cells relative to GFP control transduction (Fig. 5A ). In accordance with our previous studies (39) (Fig. 5B, 5C , GFP, and data not shown). However, increased expression of BAFFR did not promote normal generation of transitional BCR-low B cells (as compared with 3-83Igi,H-2 d B cells in Fig. 3 ), but only slightly increased their frequency to 1-8% (Fig. 5B, 5C , BAFFR). Increased BAFFR expression was also unable to restore normal generation of BCRlow transitional and mature B cells in vivo (Supplemental Fig. 3) , and similar results were obtained when BAFFR expression was enforced on autoreactive 3-83Igi,Rag1 2/2 ,H-2 b immature B cells (Supplemental Fig. 4) .
As mentioned above, expression of N-RasD12 was able to complement suboptimal tonic BCR signaling in BCR-low immature B cells, promoting higher levels of BAFFR expression (Fig. 2C, 2D) , and differentiation into transitional and mature B cells (39) . However, it remained unclear whether the differentiation process mediated by N-RasD12 was still dependent on, or rather independent of, the presence of BAFF. Therefore, we transduced BCR-low immature B cells with N-RasD12 or GFP only encoding retroviruses and assessed their differentiation in vitro in the presence or absence of BAFF. In contrast to the poor differentiation attained with increasing only BAFFR expression (Fig. 5C ), optimal in vitro differentiation of BCR-low CD21 (Fig. 5D,  5E ), in accordance with what we have previously reported (39) . In addition to these data, we found that generation of transitional CD21 + CD23 + T2-like B cells in N-rasD12-transduced BCRlow cell cultures was further increased by the presence of BAFF (Fig. 5D, 5E ), suggesting that the signaling pathway activated by N-RasD12 could not completely substitute for the absence of BAFFR signaling.
Overall, these data indicate that reduced tonic BCR signaling is responsible for the reduced differentiation of BCR-low CD21 To test whether BAFF functions in the generation of transitional T1 B cells in vivo, we established mixed bone marrow chimeras by combining either C57BL/6 Ly5.2 BAFFR-deficient or -sufficient bone marrow cells with C57BL/6 Ly5.1 congenic wild-type bone marrow cells (Fig. 6A and Supplemental Table 1 ). These chimeric mice allowed us to compare the differentiation ability of BAFFRdeficient B cells to that of BAFFR-sufficient B cells side by side, thus representing a more stringent test for the function of BAFFR in B cell development. Mixed bone marrow chimeras were analyzed by flow cytometry 6 wk after their reconstitution to determine the frequency of BAFFR-sufficient and -deficient Ly5.2 + donor cells in pro-B, pre-B, immature B, transitional B, and follicular B cell populations in bone marrow and spleen tissues (gated as shown in Supplemental Fig. 5A ). In the spleen, transitional B cells were gated based on high levels of CD24 expression, which discriminates them from more mature B cells (22 pro-B and pre-B cells (52) . As shown in Fig. 6B (filled bars) , the frequency of BAFFR-sufficient B cells remained fairly stable throughout B cell development, as indicated by the fact that similar frequencies of Ly5.2 + wild-type B cells were observed at all B cell stages. In contrast, the frequency of BAFFR-deficient B cells was significantly decreased at the CD24 high CD23
+ T2/T3 transitional B cell and CD24 low CD23 + mature follicular B cell stages in the spleen of bone marrow chimeric mice relative to their precursor B cell populations in the same animals (Fig. 6B, open  bars) . These data indicate that BAFFR plays a significant role in the generation and maintenance of T2, T3, and mature B cells, confirming previous observations (9) . In addition to these anticipated results, we also found that the frequency of BAFFRdeficient transitional CD24 high CD23
2 T1 (and immature) B cells in the spleen was significantly reduced to half of that of their precursor bone marrow immature B cell population in the same mice (Fig. 6B, open bars) . As shown through multiparametric flow cytometric analysis (Supplemental Fig. 5B ), spleen CD24 high Fig. 5 ). These analyses indicated that whereas the size of the transitional CD23 + B cell population was reduced in both spleen and bone marrow in the absence of BAFFR, that of the transitional CD23
2 B cell population was significantly decreased only in the spleen (Fig. 6C) (Fig. 4) . Moreover, we have found that only spleen T1, but not bone marrow T1-like, CD23 2 transitional B cells are affected by the absence of BAFFR in vivo (Fig. 6) . Thus, we questioned whether a different prosurvival cytokine could promote the generation of transitional T1-like B cells in the bone marrow.
The cytokine IL-7 has both prosurvival and differentiation functions in early B cell development (18) . However, whether IL-7 operates on immature B cells is controversial (18) , despite the fact that these cells still express IL-7R (53) . Therefore, we decided to test whether IL-7 could replace BAFF, at least partially, in the differentiation of immature B cells into transitional B cells in vitro. Fig. 7B and data not shown) . A small but significant reduction was observed in the frequency of T1-like and T2-like B cells in cultures containing both BAFF and IL-7 (Fig. 7C ), but these differences were caused by increased survival of nondifferentiated immature B cells in response to IL-7 (Fig.  7D) . In fact, cell counting indicated that T1-like and T2-like B cells were present in similar numbers in cultures containing BAFF regardless of IL-7 (Fig. 7D) .
Thus, our data indicate that IL-7 cannot replace BAFF in the generation of CD21 + CD23
2/+ transitional B cells in vitro. Importantly, however, IL-7 does not inhibit BAFF activity in this process. Moreover, other bone marrow factors that could potentially affect newly generated immature B cells in the bone marrow, such as a proliferation-inducing ligand (54, 55) , hemokinin-1 (56), and macrophage migration inhibitory factor (57), were also unable to promote differentiation of Fig. 6 ), suggesting that BAFF may be unique in this capacity. . The gating strategy used in the analysis is depicted in Supplemental Fig. 5A . pp , 0.05; ppp , 0.005; pppp , 0.001. BM, bone marrow; Fo., follicular; Imm., immature.
Discussion
The studies presented in this work were developed to test whether BAFFR is differentially expressed in autoreactive and nonautoreactive immature B cells, and whether BAFFR expression and signaling contribute to immature B cell selection. We found that BAFFR is expressed at levels 4-fold higher by nonautoreactive than autoreactive immature B cells, both at the RNA and surface protein levels. Moreover, our data indicate that BAFF contributes to the selection of immature B cells by promoting the differentiation of immature B cells into transitional B cells upon normal tonic BCR signaling.
Previous studies have shown that expression of BAFFR coincides with that of IgM during B cell development (28, 35) . Our data extend those findings by indicating that BAFFR expression is dependent on tonic BCR signaling and its level correlates with that of surface IgM. To support these conclusions, we show that immature B cells displaying low levels of IgM and tonic BCR signaling manifest low levels of BAFFR expression. Moreover, reinstatement of tonic BCR signaling by expression of the constitutive active N-RasD12 protein leads to higher BAFFR levels on BCR-low immature B cells. These data suggest that tonic BCR signaling leads to changes in the expression of nuclear proteins that promote transcription of the tnfrsf13c gene. A likely candidate for modulating tnfrsf13c gene transcription downstream of tonic BCR signaling is the NF-kB pathway, which may be activated by tonic BCR signaling and whose inhibition leads to reduced tnfrsf13c mRNA expression (58) . Additionally, previous studies have shown that tonic BCR signaling generates NF-kBp100, which is a substrate of the BAFFR signaling pathway (59) . Thus, it appears that immature B cells would be capable of responding to BAFF only upon optimal tonic BCR signaling, which increases both BAFFR expression and function.
Numerous publications have indicated that BAFF is an important factor for the survival of mature follicular and marginal zone B cells. Some reports, however, have suggested that BAFF may promote B cell differentiation as well. For instance, a reduced export of B cells from the bone marrow has been observed in BAFFR mutant A/WySnJ mice (7). Moreover, the B cell defects seen in the absence of BAFF or BAFFR cannot completely be corrected by constitutive expression of the prosurvival protein Bcl-2. Constitutive Bcl-2 expression does not rescue marginal zone B cells and only partially reinstates numbers of follicular B cells in TACI-Ig transgenic mice (51) , and it does not reconstitute normal CD21 expression in BAFFR mutant mice (9, 49) , suggesting an underlying defect in B cell generation. On the other side, constitutive Bcl-2 was able to functionally substitute for BAFF in vivo, allowing a T cell-dependent immune response to a standard Ag, but one can argue that immature/transitional B cells could be drawn into an immune response in the absence of competition with mature B cells and in the presence of the antiapoptotic Bcl-2 pathway (51 It has been proposed that BAFF regulates CD21 and CD23 expression (28) . Thus, a justified question can be raised of whether our results indicate that BAFF promotes the differentiation of immature B cells or increases the expression of the CD21 and CD23 markers that we used for transitional B cell classification. We are confident that our analyses appropriately show that BAFF promotes the differentiation of immature into transitional B cells because of the following arguments. First, more than one study has challenged the idea that BAFF regulates CD23 expression (9, 32, 48) . Thus, the use of CD23 to distinguish transitional T2 and T2-like B cells from transitional T1 and T1-like B cells in our studies seems appropriate both in the absence and in the presence of BAFF. Second, although CD21 expression is indeed influenced by BAFF, CD21 levels are only slightly (2-fold) reduced in the absence of BAFF (49) . In our studies we used CD21 to characterize the presence of CD21 + transitional B cells developing from CD21
2 immature B cells only in vitro. In these studies we were careful to gate CD21 + cells based on CD21 2 cell controls, such as BCR-negative (3-83Igi-mb1 2/2 ) and BCR-low (3-83Igi-low) immature B cells. Thus, these analyses were able to distinguish CD21 low (transitional) from CD21 2 (immature) B cells both in the presence and in the absence of BAFF. Third, IgD can also be used to distinguish transitional from immature B cells (22) , and BAFF does not appear to affect IgD expression. In our studies we observed higher levels of IgD expression and increased frequency of IgD + B cells in cultures containing BAFF, indicating an increase in B cell differentiation. Fourth, transitional T1 B cells in the spleen were gated based on high CD24 expression and the absence of CD23, markers that are not affected by BAFF. The fact that we observed a strong and significant reduction of BAFFR-deficient transitional T1 B cells in the spleen of mixed bone marrow chimeras indicates that BAFF is important for the generation of these cells, and that BAFFR signaling has an effect preceding the T2 B cell stage.
Splenic transitional B cells are classified as T1 when they are CD23 2 , and T2 or T3 when they express CD23 and depending on levels of IgM (23) . Additionally, all transitional B cells express variable amounts of IgD and CD21 (27) . Although transitional B cells are also present in bone marrow (22, 25, 26) , they are still not fully characterized in this tissue. Nevertheless, it was necessary in our studies to distinguish immature from transitional B cells in both bone marrow and spleen. Thus, we classified as transitional those cells that also upregulated expression of IgD and CD21 in bone marrow cultures and bone marrow tissues, discriminating transitional T1-like and T2-like B cells on the basis of CD23 expression. Our data indicate that BAFFR and BAFF play a larger role in T2 and T3 than in T1 B cell differentiation. In fact, differentiation of immature B cells into transitional CD23 2 B cells in bone marrow cultures, in bone marrow tissues, and in spleen occurred to some extent even in the absence of BAFF, although these processes were enhanced by the addition of BAFF.
On the other side, we show that the differentiation of transitional CD23 + B cells required BAFF both in vitro and in vivo. The differential dependency on BAFF among transitional B cell subsets may be due to the fact that BAFFR expression and BAFF binding increase with their differentiation (28) and, in fact, T1 B cells are considered the developmental precursors of both T2 and T3 B cells (27) .
An important finding supporting a role for BAFF in the differentiation of immature into transitional B cells is the inability of Bcl-2 to fully substitute for BAFF in this function. (9, 49) . In particular, the results of our in vivo competition studies highlight the possibility that the differentiation of BAFF-and BAFFRdeficient CD23 + B cells observed with and without Bcl-2 transgenes (9, 49, 51) may be the product, at least in part, of the lack of competition with normal B cells. Overall, our data support the idea that BAFF-mediated signals lead to enhanced differentiation of immature B cells into transitional T1 B cells and are necessary for the differentiation of transitional T1 B cells into T2 B cells. However, it appears that the role of BAFF in these events is secondary to that of tonic BCR signaling. We have previously shown that tonic BCR signaling is required for the generation of both CD23
2 and CD23 + transitional B cells (39) . Moreover, our present data indicate that increasing BAFFR expression in immature B cells with insufficient tonic BCR signaling does not reconstitute normal differentiation in response to BAFF, and that optimal BCR expression and function are essential for normal BAFFR expression. Thus, our data support a model in which optimal tonic BCR signaling induces the differentiation of immature B cells into early transitional T1 B cells, by initiating the expression of CD21 and IgD, as well as by increasing that of BAFFR. BAFF binding, then, triggers BAFFR signaling, causing further differentiation into cells that express higher levels of IgD and CD21 (late T1) and of CD23 (T2). Thus, a synergy between BAFFR and tonic BCR signaling appears necessary for optimal generation of transitional T1 B cells, for the differentiation of transitional T1 into transitional T2 B cells, and ultimately, therefore, for the production of mature B cells.
Immature B cells generated in the bone marrow can either migrate to the spleen for further differentiation, or first differentiate into transitional B cells within the bone marrow before migrating to the spleen (26) . Our studies show that during in vivo B cell development BAFFR signaling affects the generation of transitional T1 B cells in the spleen, but not that of T1-like B cells in the bone marrow. There are different potential explanations for this finding. For instance, it is possible that the B cells we have classified as transitional T1-like B cells in bone marrow do not belong to the same developmental stage as T1 B cells in the spleen. In support of this idea, we noticed that CD21 expression is higher on splenic T1 than on bone marrow T1-like B cells (data not shown). If so, tonic BCR signaling may be sufficient for the differentiation of immature B cells into transitional T1-like B cells in the bone marrow, while a cooperation of tonic BCR and BAFFR signals may be required for the differentiation of immature and/or T1-like B cells into the splenic transitional T1 B cell population. Another possible explanation is one related to the environment. There may be a cytokine distinct from BAFF in the bone marrow that is able to promote the differentiation of immature B cells into T1-like B cells in cooperation with tonic BCR signaling. Our data show that increased cell survival, such as that mediated by constitutive Bcl-2 expression, can substitute for BAFF to enhance the differentiation of immature B cells into transitional T1-like B cells in vitro. Thus, another prosurvival cytokine in the bone marrow could potentially relieve the need for BAFF. We tested the cytokine IL-7 in this context because IL-7 permeates the bone marrow environment and promotes early B cell survival and differentiation. Our data show, however, that IL-7 does not enhance the generation of IgD + CD21 + CD23 2 T1-like B cells in vitro. Thus, a different bone marrow cytokine may be involved in this process.
In preliminary studies we tested whether a proliferation-inducing ligand, hemokinin-1, or macrophage migration inhibitory factor may be able to substitute for BAFF in promoting the differentiation of immature B cells into transitional B cells in vitro, as these cytokines have been shown to affect B cells and are present in the bone marrow tissue (54) (55) (56) (57) . However, none of these cytokines had any effect on the upregulation of IgD, CD21, and CD23 in culture and, thus, the differentiation of immature into transitional B cells, suggesting that BAFF may be unique in this function. It has been reported that IL-7 hampers the differentiation of immature and mature B cells from their progenitors, although these data are controversial (18) . Consequently, we assessed whether IL-7 could actually counteract the effects of tonic BCR and BAFFR signaling in the differentiation of immature B cells into transitional B cells in culture. We found that tonic BCR and BAFFR signaling were both still equally capable of promoting immature B cell differentiation in the presence or absence of IL-7. The absence of an inhibitory effect by IL-7 may be related to the fact that IL-7R expression and function are low on immature B cells (18, 53) , although we have not tested whether this is the case in our system.
The differentiation of immature B cells into transitional B cells is a critical event for the proper generation of the naive B cell repertoire. More than 50% of newly generated immature B cells are autoreactive (33, 34) , and their further differentiation is unwarranted. However, nature has evolved a checkpoint that prevents positive selection of autoreactive immature B cells. Autoreactive immature B cells display low levels of surface IgM, as IgM is internalized following binding to autoantigen. Extrapolating from our analyses of BCR-low immature B cell development, the low IgM expression on autoreactive immature B cells would translate into low tonic BCR signaling that is insufficient to promote differentiation into transitional B cells, as also suggested by other studies (60) . In addition to displaying low tonic BCR signaling, we show in this study that autoreactive immature B cells are unable to upregulate expression of BAFFR. Therefore, we suggest that the absence of both optimal tonic BCR and BAFFR signaling prevents autoreactive immature B cells from further differentiation and thus contributes to their negative selection. We also envision that autoreactive immature B cells with different degrees of autoreactivity may progress to different stages of differentiation depending on levels of tonic BCR signaling and BAFFR expression. Thus, low-avidity autoreactive immature B cells, such as the prototypical anergic B cells, may progress into transitional B cells because they receive low levels of both tonic BCR and BAFFR signaling, but they fail to reach the mature B cell stage because these signals are still reduced compared with those of nonautoreactive B cells. In contrast, high-avidity autoreactive immature B cells, such as the 3-83Ig + B cells we studied in this paper, are absolutely blocked in differentiation because they do not receive any tonic BCR signaling.
Our study indicates that tonic BCR and BAFFR signals cooperate for the differentiation of normal IgM-expressing nonautoreactive immature B cells, by promoting their differentiation into transitional B cells. Therefore, tonic BCR and BAFFR signaling pathways together guide the positive selection of nonautoreactive immature B cells into the peripheral mature B cell compartment, and they are critical for shaping the naive B cell pool such that it can mount a protective humoral immune response in the absence of autoreactivity.
